IPO Financial News

Subscribe to enjoy similar stories. Dr. Agarwal’s Health Care, India’s largest eye care chain by revenue and network size, is going public with plans to raise ₹3,027 crore.

Subscribe to enjoy similar stories. As the world order shifts from globalization towards protectionism, the Indian government too has shown persistent focus on Atmanirbhar Bharat, or self-reliant India, with initiatives like production-linked incentives (PLI) schemes to encourage local manufacturing. Electronics manufacturer Dixon Technologies Ltd was among the earliest to answer the government’s call to manufacturers to ‘make in India’.

initial public offering of ₹3,027 crore comprising an offer for sale of ₹2,727 crore with the rest being a fresh issue that dilutes the promoter shareholding from 37.7% to 32.5%. Of the issue proceeds, ₹195 crore will be used to repay borrowings. Business: Incorporated in 2010, Chennai-based DAHC is India's largest eye care service chain run by fourth-generation ophthalmologists. It has the highest number of eye care facilities in the country at 193, and 16 in Africa which contributes around 10% of the total revenues. At the end of September 2024, the company had 737 doctors and earned 66% of its revenues from surgeries, 13% from diagnosis and non-surgical treatments and 21% through the sale of eye care-related products, opticals, contact lenses and accessories.

It is interacting with potential underwriters for the share offering in London, where Hero Future's chairman, Rahul Munjal, has been spending considerable time to help expand the global footprint of the renewable energy generator, said the sources cited above.

Subscribe to enjoy similar stories. Dr. Agarwal's Health Care Ltd's initial public offering (IPO) represents a milestone for India’s specialized healthcare sector.

Subscribe to enjoy similar stories. The Nifty 50, India's benchmark index, extended its losing streak for a second consecutive session on Monday, 27 January, closing below 22,829.15. The index opened the day with a gap-down at 22,940 and remained range-bound between 22,786 and 23,007.

Subscribe to enjoy similar stories. Companies use various corporate actions, such as dividends, bonus shares, stock splits, and buybacks, to reward shareholders, distribute reserves, and improve market liquidity.

Subscribe to enjoy similar stories. Insurtech startup InsuranceDekho has raised capital from Beams Fintech Fund, MUFG Bank and C. Development, documents filed with the ministry of corporate affairs showed.

Brainbees Solutions, the parent company of the FirstCry brand, fell 2.3% on Monday to Rs 457.10 on the BSE, extending a recent losing streak as concerns over an impending pre-IPO lock-in expiry loomed large. Brokerage JM Financial maintained its “buy” rating on the stock but slashed its target price to Rs 667, still implying a robust 46% upside from current levels. The stock has been under pressure ahead of the February 13 lock-in expiry, which will make nearly 60% of the company’s share capital — over 300 million shares — eligible for trading. This volume dwarfs the stock’s average daily trading volume of around 760,000 shares and has heightened fears of selling pressure.

IPO is entirely a fresh issue of 2 crore equity shares, according to the draft red herring prospectus (DRHP). The company is planning to use Rs 289.4 crore out of the IPO proceeds for acquisition of dry bulk carriers in the supramax category in the secondary market, and further use Rs 19.5 crore for repaying debt.

Malpani Pipes and Fittings is set to launch its SME initial public offering (IPO) on January 29, 2025, with a price band of Rs 85-90 per share. The IPO aims to raise Rs 25.92 crore through the issuance of 28.80 lakh fresh shares. Specializing in the manufacturing of high-quality pipes, including HDPE, MDPE, LLDPE, and Sprinkler and Drip Pipes under the Volstar brand, Malpani Pipes serves key sectors such as irrigation, telecommunications, and infrastructure.

Barclays hasn't announced its 2024 bonuses yet, but when it does, there are signs that they could be a bit different. 

It's nearly a year since the merger between Panmure Gordon and Liberum, and Panmure Liberum is still right-sizing its teams.

Banks in London are cutting jobs. But the numbers are in the 10s rather than the 100s. 

Dr Agarwals Eye Hospital would utilize the funds raised through the forthcoming Initial Public Offering for payment of debts and to meet some general corporate purposes, an official said. The city-headquartered company, backed by Temasek Holdings and TPG is proposing to raise an aggregate of Rs 3,027.26 crore through its maiden IPO to open from January 29 to 31 at a price band of Rs 382 to Rs 402 per share. The public issue would be a combination of a 'fresh issue' of up to Rs 300 crore and an Offer for Sale of up to 6.78 crore equity shares worth Rs 2,727.26 crore by promoters and other shareholders.

new issues, the Street will also witness 6 listings. Denta Water, which received a massive subscription of 200 times for its IPO, will see its shares get listed on January 29.

Subscribe to enjoy similar stories. US president Donald Trump issued a flurry of executive orders on his first day that have left investors on the edge. Meanwhile, small businesses are likely to receive a financial boost in the budget, while India’s top IT firms have reported subdued December-quarter earnings.

Subscribe to enjoy similar stories. Mumbai: In 1994, the Agarwal family launched a ₹4 crore initial public offering (IPO) for Dr Agarwal’s Eye Hospital, with a view towards expanding in Tamil Nadu. Thirty years later, the family is launching a ₹3,027 crore IPO of the holding company next week, which will value both entities at over $1.5 billion ( ₹12,810 crore).

Subscribe to enjoy similar stories. Mukul Agrawal, founder of Param Capital Group, is a prominent name in Indian stock markets. With over two decades of bold investing, he’s renowned for spotting multibagger opportunities and shaping market strategies, earning the trust of seasoned investors.

Subscribe to enjoy similar stories. MUMBAI : Foreign institutional investors (FIIs) didn't entirely flee India in 2024, after all. They adopted a two-pronged approach: booking profit in the secondary market while placing bets in the equity capital market (ECM) by way of initial public offerings (IPOs), follow-on offerings (FPOs), and qualified institutional placements (QIPs).

₹66 crore from anchor investors. The offering, priced between ₹279 and ₹294 per share, will close for public subscription on Friday.The initial public offering is a completely new issuance of 7.5 million equity shares valued at ₹220.5 crores at the maximum end of the price range.